Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile
Raul G Nogueira, MD, FAHA, FSVIN

@raulnogueiramd

Director, UPMC Stroke Institute
Endowed Professor & Division Chief of Cerebrovascular Medicine
Professor of Neurology & Neurosurgery
University of Pittsburgh

ID: 1520771178159292416

calendar_today01-05-2022 14:24:57

8 Tweet

1,1K Followers

25 Following

Gate.io (@gate_io) 's Twitter Profile Photo
Gate.io
@gate_io

5 hours ago

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358
Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo
Raul G Nogueira, MD, FAHA, FSVIN
@raulnogueiramd

3 years ago

We can finally announce that the overwhelming effect of EVT persists in the Posterior Circulation. A big thanks to the ATTENTION and BAOCHE Investigators! Tudor G. Jovin, MD

We can finally announce that the overwhelming effect of EVT persists in the Posterior Circulation. A big thanks to the ATTENTION and BAOCHE Investigators! <a href="/TudorGJovin/">Tudor G. Jovin, MD</a>
iCure Stroke (@icurestroke) 's Twitter Profile Photo
iCure Stroke
@icurestroke

3 years ago

Are you ready for the #icurestroke2022 ? Here is the first day details... Scientific program is now online! Click the link to find out more and we can't wait to see you in person in Istanbul: icurestroke.org #icurestroke #stroke #thrombectomy #dekoncongress

Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo
Raul G Nogueira, MD, FAHA, FSVIN
@raulnogueiramd

3 years ago

#icure IL Marc Demetrius Lopes, MD Atilla Ă–zcan Ă–zdemir iCURE 2022 - thanks everyone for an amazing meeting. Stay tune for videos of live stroke cases. Coming up in the website soon.

#icure <a href="/italolinfante/">IL</a> <a href="/marcriboj/">Marc</a> <a href="/Cure4Stroke/">Demetrius Lopes, MD</a> <a href="/zcanzde13818658/">Atilla Ă–zcan Ă–zdemir</a> iCURE 2022 - thanks everyone for an amazing meeting. Stay tune for videos of live stroke cases. Coming up in the website soon.
Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo
Raul G Nogueira, MD, FAHA, FSVIN
@raulnogueiramd

2 years ago

Congratulations to the WSO for an amazing conference in Toronto. I’m honored for being the recipient of 2023 World Stroke Organization Presidential Award. Thanks to everyone who presented their great science at the meeting. See you in 2024 World Stroke Org sheila martins

Congratulations to the WSO for an amazing conference in Toronto. I’m honored for being the recipient of 2023 World Stroke Organization Presidential Award. Thanks to everyone who presented their great science at the meeting. See you in 2024 <a href="/WorldStrokeOrg/">World Stroke Org</a> <a href="/sheilambrasil/">sheila martins</a>
Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo
Raul G Nogueira, MD, FAHA, FSVIN
@raulnogueiramd

7 months ago

Honored to present RESILIENT as a proof of concept for MT in the public healthcare systems of low- and middle-income countries at the G20 Mtg. Kudos to the organizers, and a heartfelt thanks to Sheila Martins for her leadership in transforming stroke for the underserved world.

Raul G Nogueira, MD, FAHA, FSVIN (@raulnogueiramd) 's Twitter Profile Photo
Raul G Nogueira, MD, FAHA, FSVIN
@raulnogueiramd

6 months ago

Grateful to the patients, families, and investigators who contributed to VERITAS. Efficacy at extremes of severity (NIHSS<9; pc-ASPECTS 0-5) remains uncertain, but MT benefits a broad range of VBAO patients within 24h, regardless of age, IVT use, etiology, or occlusion level.

Grateful to the patients, families, and investigators who contributed to VERITAS. Efficacy at extremes of severity (NIHSS&lt;9; pc-ASPECTS 0-5) remains uncertain, but MT benefits a broad range of VBAO patients within 24h, regardless of age, IVT use, etiology, or occlusion level.